NCT02039557
Long Term Follow Up Protocol for NiCord®/CordIn™ (Omidubicel) Patients
COMPLETED
NCT02039557
OBSERVATIONAL
Long Term Follow Up for Patients Who Have Received Allogeneic Stem Cell Transplantation of NiCord®/CordIn™, Umbilical Cord Blood-derived Ex Vivo Expanded Stem and Progenitor Cells
This is an observational study that will monitor clinical outcomes of patients who have received a NiCord®/CordIn™ (omidubicel) transplant as part of a GC clinical interventional study and meet the eligibility criteria for this Long Term Follow Up study.
Inclusion Criteria
* Anyone who has received a NiCord®/CordIn™ (omidubicel) transplant, completed study specific follow up, and has signed the consent for this study.
Exclusion Criteria
* None
Patients Transplanted With NiCord/CordIn (Omidubicel)
-
- Type: GENETIC
- Name: NiCord®/CordIn™ (omidubicel)
- Description:
- Arm Group Labels: NiCord®/CordIn™ (omidubicel) transplanted
- Gamida Cell ltd